Status: current, Defined. Date: 30-Nov 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2818331000168115 | Bosentan (Actelion) (bosentan 62.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2818341000168112 | Bosentan (Actelion) 62.5 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bosentan (Actelion) 62.5 mg tablet | Is a | Bosentan (Actelion) | true | Inferred relationship | Some | ||
| Bosentan (Actelion) 62.5 mg tablet | Is a | bosentan 62.5 mg tablet | true | Inferred relationship | Some | ||
| Bosentan (Actelion) 62.5 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Bosentan (Actelion) 62.5 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Bosentan (Actelion) 62.5 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1778566273 | |
| Bosentan (Actelion) 62.5 mg tablet | has intended active ingredient | bosentan | true | Inferred relationship | Some | 1778566272 | |
| Bosentan (Actelion) 62.5 mg tablet | has Australian BoSS | bosentan | true | Inferred relationship | Some | 1778566272 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bosentan (Actelion) 62.5 mg tablet, 60 | has TPUU | True | Bosentan (Actelion) 62.5 mg tablet | Inferred relationship | Some | 1 |
| Bosentan (Actelion) 62.5 mg tablet, 60, bottle | has TPUU | True | Bosentan (Actelion) 62.5 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR